» Articles » PMID: 39407781

Antibody-Mediated Nodo- and Paranodopathies

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 Oct 16
PMID 39407781
Authors
Affiliations
Soon will be listed here.
Abstract

The recent discovery of pathogenic antibodies targeting cell adhesion molecules of the node of Ranvier has prompted efforts to develop a new classification for a subset of antibody-mediated peripheral neuropathies. These autoimmune nodo- and paranodopathies encompass epitopes such as neurofascin 155, neurofascin 186, contactin-1, and contactin-associated protein 1, with a high likelihood of involving additional yet unidentified proteins. So far, the investigation of this subset of patients was primarily focused on adults, with only rare reports of pediatric cases. Low awareness among pediatricians and insufficient availability of appropriate diagnostic methods in many laboratories may mask a higher pediatric incidence than currently observed. Diagnosis is made by transfected cell-based assays and ELISA to characterize the specific target antigen and antibody subclass that provides insight into the pathophysiology. Clinical features often resemble those of CIDP or GBS in adults, whilst in pediatric patients, although rare, an atypical CIDP phenotype has predominantly been reported. Yet, in contrast to classical immune-mediated neuropathies, the clinical course is usually rapidly progressive, and response to classical first-line therapy often poor. Although electrophysiological signs of demyelination are observed, segmental demyelination and inflammation are not present on pathological examination. Rather, few neuropathological reports demonstrate features of axonal neuropathy without signs of true de- or remyelination. This review aims to summarize recent findings on such nodo- and paranodoneuropathies, shining light on features of these disorders in pediatric patients, a still little-explored field with only a few reports currently present.

References
1.
Poliak S, Salomon D, Elhanany H, Sabanay H, Kiernan B, Pevny L . Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J Cell Biol. 2003; 162(6):1149-60. PMC: 2172860. DOI: 10.1083/jcb.200305018. View

2.
Vural A, Doppler K, Meinl E . Autoantibodies Against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic Relevance. Front Immunol. 2018; 9:1029. PMC: 5960694. DOI: 10.3389/fimmu.2018.01029. View

3.
Dong M, Tai H, Yang S, Gao X, Pan H, Zhang Z . Characterization of the patients with antibodies against nodal-paranodal junction proteins in chronic inflammatory demyelinating polyneuropathy. Clin Neurol Neurosurg. 2022; 223:107521. DOI: 10.1016/j.clineuro.2022.107521. View

4.
Van den Bergh P, van Doorn P, Hadden R, Avau B, Vankrunkelsven P, Allen J . European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. Eur J Neurol. 2021; 28(11):3556-3583. DOI: 10.1111/ene.14959. View

5.
Liberatore G, de Lorenzo A, Giannotta C, Manganelli F, Filosto M, Cosentino G . Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database. Neurol Sci. 2022; 43(6):3939-3947. DOI: 10.1007/s10072-021-05811-0. View